Evaluation of Laboratory Findings of Patients with Coronavirus Disease ۲۰۱۹ in Kerman, Iran

Background & Objective: Since December ۲۰۱۹ in Wuhan, China there is a new form of pneumonia and after expansion in other countries, World Health Organization (WHO) called it Coronavirus Disease ۲۰۱۹ (COVID-۱۹). Since the clinical laboratory findings have played an important role in the progression of the disease, this study aimed to evaluate the laboratory findings in COVID-۱۹ patients (before vaccination).Methods: In this case-control study that was conducted from February to August ۲۰۲۰; the laboratory test status in ۱۰۱ positive COVID-۱۹ patients was evaluated and compared with ۱۰۱ healthy individuals.Results: The results of our study showed that ۲۱% of patients had low WBC, ۲۴.۷۵% low RBC, ۳۷.۶۲%, low Hb, ۱۸.۸۱% with low HCT, ۲۹.۷%, low Plt, ۴۱.۵۸% had High PT, ۷۱.۲۹% high CRP, ۱۷.۸۲% high urea, ۱۱.۸۸% high CR, ۱۵.۸۴% high LDH, ۱۰.۸۹% low sodium, ۱۴.۷۵% low potassium (K). The quantitative examination of blood factors showed that lymph%, mixed%, PLT, HCT, Hb, and RBC were higher in the control group than in the case group. While Neu%, WBC, PTT, CRP, UREA, LDH, K in the patient group were higher than in the control group.Conclusion: According to the results of the study, it can be concluded that in the clinical treatment of COVID-۱۹ patients, much attention should be paid to the laboratory indicators to identify and intervene early in critically ill patients.

Keywords:

COVID-۱۹ , laboratory test , Coronavirus